Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more
Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Net Assets
Latest net assets as of September 2025: CN¥3.27 Billion CNY
Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has net assets worth CN¥3.27 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.44 Billion) and total liabilities (CN¥1.16 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.27 Billion |
| % of Total Assets | 73.75% |
| Annual Growth Rate | 22.92% |
| 5-Year Change | 3.59% |
| 10-Year Change | 518.13% |
| Growth Volatility | 55.48 |
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)
The table below shows the annual net assets of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.14 Billion | +4.37% |
| 2023-12-31 | CN¥3.01 Billion | -0.09% |
| 2022-12-31 | CN¥3.01 Billion | -6.64% |
| 2021-12-31 | CN¥3.23 Billion | +6.41% |
| 2020-12-31 | CN¥3.03 Billion | +20.53% |
| 2019-12-31 | CN¥2.52 Billion | +36.70% |
| 2018-12-31 | CN¥1.84 Billion | +214.68% |
| 2017-12-31 | CN¥585.03 Million | +14.85% |
| 2016-12-31 | CN¥509.40 Million | +0.21% |
| 2015-12-31 | CN¥508.35 Million | +52.38% |
| 2014-12-31 | CN¥333.61 Million | +8.49% |
| 2013-12-31 | CN¥307.51 Million | +16.75% |
| 2012-12-31 | CN¥263.39 Million | +22.60% |
| 2011-12-31 | CN¥214.83 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Beijing New Oriental Star Petrochemical Engineering Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 174037299300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.74 Billion | 56.83% |
| Common Stock | CN¥928.16 Million | 30.31% |
| Other Comprehensive Income | CN¥260.28 Million | 8.50% |
| Other Components | CN¥133.83 Million | 4.37% |
| Total Equity | CN¥3.06 Billion | 100.00% |
Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Market Cap
The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A
SHE:301246
|
$461.09 Million |
|
Shenzhen Liande Automatic Equipment Co Ltd
SHE:300545
|
$461.09 Million |
|
Gs Retail
KO:007070
|
$461.29 Million |
|
NGERN TID LOR-NVDR- BA37
F:70V0
|
$461.29 Million |
|
Sipef S.A.
LSE:0JSU
|
$460.94 Million |
|
Nagacorp Ltd
PINK:NGCRF
|
$460.72 Million |
|
Columbia Financial Inc
NASDAQ:CLBK
|
$460.69 Million |
|
Goldcard High-Tech Co Ltd
SHE:300349
|
$460.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beijing New Oriental Star Petrochemical Engineering Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,899,985,004 to 3,062,651,954, a change of 162,666,950 (5.6%).
- Net income of 160,294,271 contributed positively to equity growth.
- Dividend payments of 1,157,971 reduced retained earnings.
- Other comprehensive income increased equity by 253,705,763.
- Other factors decreased equity by 250,175,113.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥160.29 Million | +5.23% |
| Dividends Paid | CN¥1.16 Million | -0.04% |
| Other Comprehensive Income | CN¥253.71 Million | +8.28% |
| Other Changes | CN¥-250.18 Million | -8.17% |
| Total Change | CN¥- | 5.61% |
Book Value vs Market Value Analysis
This analysis compares Beijing New Oriental Star Petrochemical Engineering Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 8.78x to 4.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥1.67 | CN¥14.68 | x |
| 2012-12-31 | CN¥2.04 | CN¥14.68 | x |
| 2013-12-31 | CN¥2.38 | CN¥14.68 | x |
| 2014-12-31 | CN¥2.56 | CN¥14.68 | x |
| 2015-12-31 | CN¥3.33 | CN¥14.68 | x |
| 2016-12-31 | CN¥3.25 | CN¥14.68 | x |
| 2017-12-31 | CN¥0.68 | CN¥14.68 | x |
| 2018-12-31 | CN¥2.44 | CN¥14.68 | x |
| 2019-12-31 | CN¥2.71 | CN¥14.68 | x |
| 2020-12-31 | CN¥3.26 | CN¥14.68 | x |
| 2021-12-31 | CN¥3.47 | CN¥14.68 | x |
| 2022-12-31 | CN¥3.19 | CN¥14.68 | x |
| 2023-12-31 | CN¥3.12 | CN¥14.68 | x |
| 2024-12-31 | CN¥3.25 | CN¥14.68 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beijing New Oriental Star Petrochemical Engineering Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.23%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.02%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 1.32x
- Recent ROE (5.23%) is below the historical average (36.53%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 22.87% | 9.29% | 1.19x | 2.08x | CN¥27.65 Million |
| 2012 | 22.76% | 2.94% | 3.37x | 2.30x | CN¥33.62 Million |
| 2013 | 18.06% | 11.36% | 0.84x | 1.89x | CN¥24.77 Million |
| 2014 | 11.24% | 7.96% | 0.81x | 1.75x | CN¥4.14 Million |
| 2015 | 100.13% | 16.90% | 4.20x | 1.41x | CN¥458.18 Million |
| 2016 | 123.67% | 20.37% | 4.48x | 1.36x | CN¥579.04 Million |
| 2017 | 117.02% | 17.84% | 3.93x | 1.67x | CN¥555.62 Million |
| 2018 | 36.45% | 17.04% | 1.33x | 1.61x | CN¥486.25 Million |
| 2019 | 31.07% | 17.28% | 1.22x | 1.47x | CN¥529.60 Million |
| 2020 | 23.84% | 19.08% | 0.99x | 1.26x | CN¥418.91 Million |
| 2021 | 11.80% | 12.23% | 0.83x | 1.16x | CN¥58.04 Million |
| 2022 | -7.62% | -12.06% | 0.55x | 1.15x | CN¥-522.12 Million |
| 2023 | -5.12% | -10.29% | 0.41x | 1.22x | CN¥-438.53 Million |
| 2024 | 5.23% | 9.02% | 0.44x | 1.32x | CN¥-145.97 Million |
Industry Comparison
This section compares Beijing New Oriental Star Petrochemical Engineering Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $2,123,990,643
- Average return on equity (ROE) among peers: -0.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) | CN¥3.27 Billion | 22.87% | 0.36x | $461.00 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $6.47 Billion | 9.88% | 3.77x | $616.08 Million |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.18 Billion | 2.74% | 0.95x | $320.56 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $10.33 Billion | 15.07% | 0.27x | $3.03 Billion |
| Wedge Industrial Co Ltd (000534) | $298.72 Million | 1.96% | 0.38x | $1.77 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $35.11 Million | 18.13% | 0.80x | $5.62 Billion |
| Hainan Haiyao Co Ltd (000566) | $353.98 Million | -9.58% | 0.80x | $702.18 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $269.51 Million | -61.02% | 1.05x | $317.08 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $927.49 Million | 2.65% | 1.38x | $425.60 Million |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $1.11 Billion | 7.32% | 0.29x | $2.05 Billion |
| Renhe Pharmacy Co Ltd (000650) | $261.49 Million | 10.60% | 0.82x | $777.45 Million |